🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Goldman Sachs

191 posts
Read More

Swiggy near Rs 177: Has a 59% share-price decline made Instamart’s losses worth the risk?

Swiggy Limited shares have fallen 59% from their 52-week high as Instamart's expansion continues to weigh on consolidated profitability. With food delivery generating record adjusted EBITDA, quick commerce losing ₹895 crore in the September quarter and management targeting a much larger business before breakeven, investors face a fundamental question about how much of the expected recovery is already reflected in the company's valuation.
Read More

Perrigo (PRGO) agrees to sell $380m infant formula business for $40m upfront as impairment looms

Perrigo has agreed to sell its US infant formula business to MeridianMade for up to $175 million, although only $40 million is payable at closing. The planned divestiture could improve margins and reduce future manufacturing investment, but a substantial impairment charge and weak growth in its remaining consumer health business complicate the turnaround.
Read More

PAG to acquire 51% of Evergrande Property Services for HK$4bn in liquidation-linked sale

PAG has agreed to acquire control of Evergrande Property Services from liquidators of its former parent, setting up a mandatory cash offer for remaining shareholders. The transaction could separate a profitable property management business from China Evergrande's collapse, but the discounted offer, outstanding receivables and regulatory conditions complicate the investment case.
Read More

Anthropic files Nasdaq IPO as $16.3bn revenue meets staggering $80.7bn accounting loss

Anthropic has publicly filed for a Nasdaq listing under the proposed ticker ANT, disclosing extraordinary revenue growth, a multibillion-dollar accounting loss and a governance structure that preserves founder control. The filing offers investors their first detailed opportunity to evaluate the economics of the Claude developer before its anticipated stock market debut.
Read More

Parkview Health to acquire Ovation Healthcare, expanding rural hospital services across 48 states

Indiana nonprofit Parkview Health has agreed to acquire Ovation Healthcare, extending its hospital management, revenue cycle and administrative services strategy to a national network of more than 500 healthcare organizations. The transaction could help independent hospitals access operational resources without surrendering local control, although the purchase price and financial terms remain undisclosed.
Editorial infographic showing Proofpoint’s planned acquisition of Varonis, with a cybersecurity-themed background and key deal terms including a $6.3 billion transaction value, a $49.75 per share cash offer, a 52% premium to the June 22 reference price, Varonis SaaS annual recurring revenue of $726 million, and an expected closing in the first half of 2027.
Read More

Proofpoint to acquire Varonis for $6.3bn as Thoma Bravo targets AI security market

Proofpoint's proposed acquisition of Varonis Systems combines email and identity-focused threat protection with data security and AI governance capabilities. The $49.75-per-share cash offer delivers a substantial premium to historical trading levels, but its strategic value will depend on integration, enterprise adoption and the economics of a highly valued cybersecurity business.
Read More

Bank of America (NYSE: BAC) steps up Wall Street hiring after senior dealmaker departures

Bank of America has lost several senior investment bankers to rivals during a strong capital-markets cycle but says it has recruited more than 40 managing directors this year. The talent battle raises a high-value workforce question for Wall Street: whether franchise strength can offset the loss of individual rainmakers when competitors are willing to pay aggressively for client relationships.